Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gibson

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|August 27, 2021
Changes in the Proteome Profile of People Achieving Remission of Type 2 Diabetes after Bariatric SurgeryZohaib Iqbal, Helene A Fachim, J Martin Gibson, et al.
Endocrinology, Diabetes & Metabolism|July 12, 2019
Male hypogonadism: 14-year prospective outcome in 550 men with type 2 diabetesNagaraj S Malipatil, Ghasem Yadegarfar, Mark Lunt, et al.
Journal of Clinical Lipidology|December 17, 2017
A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trialHandrean Soran, Yifen Liu, Safwaan Adam, et al.
Endocrine Connections|June 20, 2013
IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetesRam P Narayanan, Bo Fu, Adrian H Heald, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 31, 2025
Progression of albumin/creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) over 24 years in people with type 2 diabetes. Drivers, potential protectors and associated mortalityAndreas Matheou, Orestis Zavlis, Steve White, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 17, 2026
The insulin-like growth factor system and the progression of renal complications of type 2 diabetesAdrian Heald, Yasitha Lllangasekera, Andreas Matheou, et al.
Cardiovascular Endocrinology & Metabolism|February 26, 2021
Androgen receptor-reduced sensitivity is associated with increased mortality and poorer glycaemia in men with type 2 diabetes mellitus: a prospective cohort studyAdrian H Heald, Ghasem Yadegar Far, Mark Livingston, et al.
Lancet (London, England)|September 15, 2017
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trialAshley Woodcock, Jørgen Vestbo, Nawar Diar Bakerly, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2014
Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apneaRahul Yadav, Michael France, Reza Aghamohammadzadeh, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 13, 2022
Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk FactorsAdrian H Heald, David A Jenkins, Richard Williams, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|August 27, 2021
Changes in the Proteome Profile of People Achieving Remission of Type 2 Diabetes after Bariatric SurgeryZohaib Iqbal, Helene A Fachim, J Martin Gibson, et al.
Endocrinology, Diabetes & Metabolism|July 12, 2019
Male hypogonadism: 14-year prospective outcome in 550 men with type 2 diabetesNagaraj S Malipatil, Ghasem Yadegarfar, Mark Lunt, et al.
Journal of Clinical Lipidology|December 17, 2017
A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trialHandrean Soran, Yifen Liu, Safwaan Adam, et al.
Endocrine Connections|June 20, 2013
IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetesRam P Narayanan, Bo Fu, Adrian H Heald, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 31, 2025
Progression of albumin/creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) over 24 years in people with type 2 diabetes. Drivers, potential protectors and associated mortalityAndreas Matheou, Orestis Zavlis, Steve White, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 17, 2026
The insulin-like growth factor system and the progression of renal complications of type 2 diabetesAdrian Heald, Yasitha Lllangasekera, Andreas Matheou, et al.
Cardiovascular Endocrinology & Metabolism|February 26, 2021
Androgen receptor-reduced sensitivity is associated with increased mortality and poorer glycaemia in men with type 2 diabetes mellitus: a prospective cohort studyAdrian H Heald, Ghasem Yadegar Far, Mark Livingston, et al.
Lancet (London, England)|September 15, 2017
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trialAshley Woodcock, Jørgen Vestbo, Nawar Diar Bakerly, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2014
Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apneaRahul Yadav, Michael France, Reza Aghamohammadzadeh, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 13, 2022
Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk FactorsAdrian H Heald, David A Jenkins, Richard Williams, et al.
Pageof 10